Schernthaner, Guntram Lehmann, Roger Prázný, Martin Czupryniak, Leszek Ducena, Kristine Fasching, Peter Janež, Andrej Karasik, Avraham Kempler, Peter Martinka, Emil Shestakova, Marina Duvnjak, Lea Tankova, Tsvetalina MOESM4 of Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG) Additional file 4: Table S1. Selected outcomes from SGLT2 inhibitor CVOTs. Type 2 diabetes;Anti-glycaemic drugs;Cardiovascular disease;Renal disease 2017-10-23
    https://springernature.figshare.com/articles/journal_contribution/MOESM4_of_Translating_recent_results_from_the_Cardiovascular_Outcomes_Trials_into_clinical_practice_recommendations_from_the_Central_and_Eastern_European_Diabetes_Expert_Group_CEEDEG_/5531293
10.6084/m9.figshare.c.3911593_D4.v1